Tradestie Institutional Equity Comparison Engine

MTVA vs PTCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTCT Overall Edge

PTCT Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PTC Therapeutics, Inc. (PTCT) driven by superior Valuation, Growth & Margin while MTVA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MTVA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PTCT at 17.7x Forward P/E and 21.5% operating margin (+69.6% YoY). In options structure, MTVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PTCT sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTCT
MTVA N/M vs PTCT 17.7x Fwd P/E
Growth & Margin Winner PTCT
Op Margin 0.0% vs 21.5% ยท YoY +0.0% vs +69.6%
Momentum & Technical Winner MTVA
1Y +32.2% vs -25.4% ยท 52W Pos 4% vs 1%
Options & Structure Winner MTVA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (11th %ile IV)
MTVA NASDAQ
MetaVia Inc. Common Stock
Pharmaceutical Preparations
$1.01
-5.61% 1D
Market Cap $7.2M
1M Return -27.34%
1Y Return +32.2%
Forward P/E N/M
Unified AI Score
48.0 / 100 HOLD
Tech 40.0 Fund 60.0 Flow 50.0 Mom 64.0
PTCT NASDAQ
PTC Therapeutics, Inc.
Pharmaceutical Preparations
$56.42
-3.27% 1D
Market Cap $4.9B
1M Return -10.5%
1Y Return -25.37%
Forward P/E 17.7x
Unified AI Score
36.3 / 100 SELL
Tech 15.0 Fund 46.0 Flow 70.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTVA +32.2% PTCT -25.37% Spread: +57.57 pp (MTVA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MTVA TTM Op. Margin: 0.0% PTCT TTM Op. Margin: 21.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MTVA vs PTCT. Trailing 12-month operating profitability (MTVA 0.0% vs PTCT 21.5%) and valuation multiples (MTVA N/M vs PTCT 17.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTVA (4) vs PTCT (6)
Institutional Metric MTVA PTCT Criterion Row Winner
Market Capitalization Scale $7.2M $4.9B Larger Scale PTCT
Trailing P/E Ratio Valuation N/M 18.0x Lower Multiple PTCT
Forward P/E Ratio Valuation N/M 17.7x Lower Multiple PTCT
Revenue Growth (YoY) Growth +0.0% +69.6% Higher Growth PTCT
Operating Margin (TTM) Profitability 0.0% 21.5% Higher Margin PTCT
Net Profit Margin Profitability 0.0% -9.2% Higher Margin MTVA
Return on Equity (ROE) Capital Efficiency -175.7% -7740.1% Higher ROE MTVA
52-Week Range Position Momentum 4% ($1โ€“$13) 1% ($56โ€“$91) Stronger Trend MTVA
Beta / 30D Volatility Risk Regime 1.30ฮฒ ยท 166% Vol 0.83ฮฒ ยท 58% Vol Lower Realized Risk PTCT
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 36.3 / 100 (SELL) Higher Composite MTVA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTVA vs PTCT Buy Guide
MTVA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTVA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PTCT BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PTCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTVA nor PTCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.